Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
To evaluate therapeutic response to MMF treatment in patients with International Society of
Nephrology/Renal Pathology Society (ISN/RPS) class III or IV lupus nephritis. Mycophenolic
acid levels at 1-hour post dose will be monitored monthly up to 6 months.